LENZ Therapeutics LENZ
NASDAQ LENZ
$3.79 -0.05 (-1.30%)
At close: Oct 1, 2026 · 4:00 PM EDT

LENZ Therapeutics (LENZ) Cash from Financing Activities (2020 - 2026)

Updated

LENZ Therapeutics (LENZ) posted Cash from Financing Activities of $395,000 for Q2 2026, down 98.5% from $26.49 million a year earlier.

Analysis

LENZ Therapeutics (LENZ) Cash from Financing Activities (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cash from Financing Activities at LENZ Therapeutics was $123.62 million, up 119.2% year-over-year; for FY2025, it was $149.75 million, down 24.8% from FY2024.

  • Annual Cash from Financing Activities shows a five-year compound annual growth rate of 37.9% (FY2020 to FY2025).
  • In prior years, LENZ Therapeutics' Cash from Financing Activities was $199 million in FY2024 (+146.6%), $80.7 million in FY2023, $597,000 in FY2022 (-99.9%) and $417.47 million in FY2021.
  • Quarterly Cash from Financing Activities has run from a low of -$2.14 million in Q2 2024 to a high of $171.27 million in Q1 2024 over five years.
  • The strongest year-over-year quarter for Cash from Financing Activities in the past five years was Q1 2024, with growth of 105.9%; the weakest was Q1 2025, with a decline of 100.0%.
  • According to Business Quant data, Cash from Financing Activities for the three prior quarters was $14,000 (Q1 2026), $122.62 million (Q4 2025) and $598,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 LENZ Therapeutics 120.64 Mn 120.64 Mn 5.21 Mn 395,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 395,000.00
Mar 31, 2026 14,000.00
Dec 31, 2025 122.62 Mn
Sep 30, 2025 598,000.00
Jun 30, 2025 26.49 Mn
Mar 31, 2025 44,000.00
Dec 31, 2024 53,000.00
Sep 30, 2024 29.82 Mn
Jun 30, 2024 -2.14 Mn
Mar 31, 2024 171.27 Mn
Dec 31, 2023 -1.91 Mn
Sep 30, 2023 -568,000.00
Mar 31, 2023 83.18 Mn
Dec 31, 2022 244,000.00
Sep 30, 2022 -59,000.00
Jun 30, 2022 412,000.00
Dec 31, 2021 313,000.00
Sep 30, 2021 31.89 Mn
Jun 30, 2021 219.50 Mn
Mar 31, 2021 165.77 Mn
API Access

LENZ Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=LENZ&period=max&api_key=YOUR_API_KEY